Merck Millipore to Introduce New Processing Technologies at BPI Conference
Merck Millipore, the life science division of Merck, will be showcasing its new biopharmaceutical processing solutions at the BioProcess International Conference & Exhibition 20–23 October in Boston. These products add to Merck Millipore's complete range of upstream and downstream products, helping to improve manufacturing productivity and accelerate time-to-market.
The new technologies on display at the BioProcess International Conference & Exhibition will include
PureFlex Plus Single-Use Process Container Film
Merck Millipore is introducing PureFlex Plus film, a robust, durable film used in the construction of Mobius single-use process containers for biopharmaceutical manufacturing. The film's rugged outer layer offers strong resistance to leak formation, making it ideal for the demanding applications often encountered in large volume operations.
The PureFlex Plus film can be used throughout the entire manufacturing process. It builds upon Merck Millipore's established PureFlex film technology by adding a new, more robust linear low density polyethlene (LLDPE) outer layer to reduce susceptibility to leaks through abrasion, puncture, stretching and tearing.
Cellvento CHO Cell Culture Media
Merck Millipore is expanding its Cellvento CHO cell culture media portfolio of chemically defined, non-animal origin media formulations for batch and fed-batch mode operations. Three new products are launching to specifically address DHFR negative cell lines: Cellvento CHO-110 medium, Cellvento CHO-210 medium and Cellvento Feed-210 media.
Cellvento CHO-110 medium is recommended for batch application and seed train expansion as its rich formulation supports high cell growth. Cellvento CHO-210 medium and its companion feeds are effective at achieving high-density cell growth and competitive productivity with DHFR negative CHO suspension cell types and expression systems, especially recombinant CHO DG44 cell lines.
NovaSeptum Single-Use Holders
NovaSeptum single-use holders are a new component of Merck Millipore's NovaSeptum fully disposable sampling systems, which help prevent contamination when sampling fluids from aseptic and sterile processes. The new single-use holders are compatible with NovaSeptum containers, helping reduce validation requirements, and can be filled with any type of container using a 2-mm trigger.
Ready-to-use, flexible and fully validated, the single-use holders are ideal for manufacturers dealing with recombinant proteins, vaccines and mAbs who need to autoclave before starting their processes.
Chromabolt Chromatography Resins
Merck Millipore is announcing the availability of three new chromatography resins for its Chromabolt prepacked columns. These pre-validated chromatography columns can come packed with either strong cation exchangers, weak cation exchangers or strong anion exchangers, freeing up end users' time and resources by eliminating manual column packing and cleaning.
Chromabolt columns are available in three sizes — 10 cm, 20 cm and 32 cm inner diameter (i.d.) — and are designed for pilot and early clinical manufacturing. The three new resins are Fractogel EMD SE Hicap, Fractogel EMD COO(M), and Eshmuno Q.
Merck Millipore will also be presenting at the BioProcess International Conference & Exhibition:
Integrated Single-Use Purification Technologies Enabling Continuous MAb Processing
Presented by Michael W. Phillips
Director, Technology Development, Merck Millipore
Tuesday, 21 October,12:00 p.m.
The Development of a More Physically Robust Single-Use Fluid Management Film for Demanding Bioprocess Applications
Presented by Michael Felo, Group Product Manager, Single Use, Merck Millipore
Wednesday, 22 October, 1:15 p.m.–1:35 p.m.
BioProcess International Theater
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...